Literature DB >> 34450461

Sleep disturbances by disease type and stage in Huntington's disease.

Amy C Ogilvie1, Peg C Nopoulos2, Jordan L Schultz3.   

Abstract

INTRODUCTION: Sleep disturbances are a common symptom in patients with Huntington's disease (HD). However, it is unclear when in the disease course of HD sleep disturbances become more frequent compared to the general population. This study investigated the frequency and odds of developing sleep disturbances between adults with HD or at-risk for HD and non-HD controls.
METHODS: Participants from the Enroll-HD study were split by both disease type and disease severity using CAG length, diagnostic confidence level, and total functional capacity score. Multivariate logistic regression was used to calculate odds ratios adjusted for age, sex, tobacco and alcohol use, depression and psychosis scores, and cognition to compare HD groups to non-HD controls. Cox proportional hazards models and Kaplan Meier curves were used to determine differences in probabilities of developing sleep disturbances and how sleep disturbances are related to age at motor onset.
RESULTS: There were significant differences between HD participants and non-HD controls in both the disease type and disease stage analyses (p < 0.001). The odds of a sleep disturbance increased with worsening disease stage and was highest in those with juvenile HD. The development of a sleep disorder in manifest HD participants was observed to be around the time of disease onset.
CONCLUSIONS: Sleep disturbances are more frequent in HD patients than those without HD. There are also differences based on disease type and stage. This is supplemented by the finding that the onset of sleep disturbances occurs near the time of motor onset of HD.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Disease progression; Huntington disease; Sleep; Sleep wake disorders

Mesh:

Year:  2021        PMID: 34450461      PMCID: PMC8842493          DOI: 10.1016/j.parkreldis.2021.08.011

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.402


  28 in total

1.  Challenges assessing clinical endpoints in early Huntington disease.

Authors:  Jane S Paulsen; Chiachi Wang; Kevin Duff; Roger Barker; Martha Nance; Leigh Beglinger; David Moser; Janet K Williams; Sheila Simpson; Douglas Langbehn; Daniel P van Kammen
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

2.  Nocturnal agitation in Huntington disease is caused by arousal-related abnormal movements rather than by rapid eye movement sleep behavior disorder.

Authors:  Dulce Neutel; Maya Tchikviladzé; Perrine Charles; Smaranda Leu-Semenescu; Emmanuel Roze; Alexandra Durr; Isabelle Arnulf
Journal:  Sleep Med       Date:  2015-03-03       Impact factor: 3.492

3.  The role of melatonin in sleep disturbances in end-stage Huntington's disease.

Authors:  Judith Alders; Marcel Smits; Berry Kremer; Paul Naarding
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2009       Impact factor: 2.198

4.  Sleep disturbance and Huntingdon's disease.

Authors:  N Taylor; D Bramble
Journal:  Br J Psychiatry       Date:  1997-10       Impact factor: 9.319

Review 5.  Sleep disturbance and psychiatric disorders.

Authors:  Daniel Freeman; Bryony Sheaves; Felicity Waite; Allison G Harvey; Paul J Harrison
Journal:  Lancet Psychiatry       Date:  2020-07       Impact factor: 27.083

6.  Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease.

Authors:  A Jennifer Morton; Nigel I Wood; Michael H Hastings; Carrie Hurelbrink; Roger A Barker; Elizabeth S Maywood
Journal:  J Neurosci       Date:  2005-01-05       Impact factor: 6.167

7.  Detection of early behavioral markers of Huntington's disease in R6/2 mice employing an automated social home cage.

Authors:  Olga Rudenko; Vadim Tkach; Vladimir Berezin; Elisabeth Bock
Journal:  Behav Brain Res       Date:  2009-05-03       Impact factor: 3.332

8.  Asymptomatic sleep abnormalities are a common early feature in patients with Huntington's disease.

Authors:  Anna O G Goodman; Lorraine Rogers; Samantha Pilsworth; Catherine J McAllister; John M Shneerson; A Jennifer Morton; Roger A Barker
Journal:  Curr Neurol Neurosci Rep       Date:  2011-04       Impact factor: 5.081

9.  Investigating the relationships between hypothalamic volume and measures of circadian rhythm and habitual sleep in premanifest Huntington's disease.

Authors:  Danielle M Bartlett; Juan F Domínguez D; Alvaro Reyes; Pauline Zaenker; Kirk W Feindel; Robert U Newton; Anthony J Hannan; James A Slater; Peter R Eastwood; Alpar S Lazar; Mel Ziman; Travis Cruickshank
Journal:  Neurobiol Sleep Circadian Rhythms       Date:  2018-07-03

10.  CAG Repeat Not Polyglutamine Length Determines Timing of Huntington's Disease Onset.

Authors: 
Journal:  Cell       Date:  2019-08-08       Impact factor: 41.582

View more
  1 in total

Review 1.  The Many Faces of Huntington's Chorea Treatment: The Impact of Sudden Withdrawal of Tiapride after 40 Years of Use and a Systematic Review.

Authors:  Stephanie Feleus; Malu van Schaijk; Raymund A C Roos; Susanne T de Bot
Journal:  J Pers Med       Date:  2022-04-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.